A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations, Trial ID 8273-CL-0202